1. FDA approves Sarepta’s DMD drug that it had previously rejected — Biogen chalks up another failure — The House passes the Lower Drug Costs Now Act, but it’s unlikely to become law — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

RSW....

Discussion in 'Arthrex' started by anonymous, Jun 16, 2019 at 11:06 PM.

  1. anonymous

    anonymous Guest

    Are the rumors true?
     
  2. anonymous

    anonymous Guest

    Randy is going, going, GONE
     
  3. anonymous

    anonymous Guest

    We met our number every time and it wasn't enough. He pushed too far
     
  4. anonymous

    anonymous Guest

    You can only have shoddy business practices for so long before you get caught.
     
  5. anonymous

    anonymous Guest

    Arthrex used and abused so many top quality performers to capture market share and surgeon loyalty that those agencies developed. Reinhold and team could care less about the individual members of their distribution network as long as Schmieding gets his name on the Forbes list of billionaires he could give a shit about any individual. Randy lost territory x2 and came back as a solid performer. Someday the Arthrex “management” team will have to work for a living rather than living off of teams like RSW.